Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Vilanterol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 known ✓ | P07550 | 20/20 | 1.00 |
| ▸ | ADRB1 | P08588 | 16/20 | 1.00 |
| ▸ | ADRB3 | P13945 | 16/20 | 1.00 |
| ▸ | MLNR | O43193 | 1/20 | 0.90 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.90 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.90 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.90 |
| ▸ | DRD1 | P21728 | 1/20 | 0.90 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.90 |
| ▸ | HTR2A | P28223 | 1/20 | 0.90 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.90 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.90 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.90 |
| ▸ | MC3R | P41968 | 1/20 | 0.90 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.90 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.90 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.90 |
| ▸ | GHSR | Q92847 | 1/20 | 0.90 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL925230 | 1.00 | ADRB2 (1.00) | ADRB2ADRB1ADRB3MLNRNR1I2 | |
| Vilanterol SCHEMBL925229 | 1.00 | ADRB2 (1.00) | ADRB2ADRB1ADRB3MLNRNR1I2 | |
| Vilanterol SCHEMBL29623445 | 0.95 | ADRB2 (1.00) | ADRB2ADRB1ADRB3MLNRNR1I2 | |
| Vilanterol SCHEMBL29352123 | 0.95 | ADRB2 (1.00) | ADRB2ADRB1ADRB3MLNRNR1I2 | |
| Vilanterol SCHEMBL118138 | 0.95 | ADRB2 (1.00) | ADRB2ADRB1ADRB3MLNRNR1I2 | |
| Vilanterol SCHEMBL15614685 | 0.95 | ADRB2 (1.00) | ADRB2ADRB1ADRB3MLNRNR1I2 | |
| SCHEMBL17031687 | 0.95 | ADRB2 (1.00) | ADRB2ADRB1ADRB3MLNRNR1I2 | |
| Vilanterol SCHEMBL142630 | 0.95 | ADRB2 (1.00) | ADRB2ADRB1ADRB3MLNRNR1I2 | |
| SCHEMBL928189 | 0.95 | ADRB2 (1.00) | ADRB2ADRB1ADRB3MLNRNR1I2 | |
| Vilanterol SCHEMBL29150309 | 0.92 | ADRB2 (0.86) | ADRB2ADRB1ADRB3MLNRNR1I2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024046339-A1 | PHARMACEUTICAL FORMULATION COMPRISING COMBINATION OF LONG-ACTING INHALED STEROID AND LONG-ACTING β2 RECEPTOR AGONIST | 立生医药(苏州)有限公司 | 2024-03-07 | — | — | WO | disclosed |
| CN-111108091-B | Novel crystalline form of vilanterol triphenylacetate and process for preparing the same | 好利安科技有限公司 | 2023-04-11 | — | — | CN | disclosed |
| CN-108135851-B | Jet milling method | 维克多瑞有限公司 | 2022-03-15 | — | — | CN | disclosed |